Molecular Formula | C15H24Cl2NO4P
|
Molar Mass | 384.24 |
Density | 1.258±0.06 g/cm3(Predicted) |
Boling Point | 544.4±50.0 °C(Predicted) |
Solubility | H2O: soluble1mg/mL, clear (warmed) |
Appearance | powder |
Color | white to beige |
pKa | 2.26±0.50(Predicted) |
Storage Condition | 2-8°C |
In vitro study | CGP52432 is a GABA B receptor antagonist, with an IC 50 of 85 nM, 35- and 100-fold lower than at the receptors regulating somatostatin and glutamate overflow, respectively. |
In vivo study | CGP52432 (10, 30 mg/kg) shows no effect on the total arm entries and total head dips of mice on the elevated-plus maze. CGP52432 (100 nmol/kg, i.v., or 1 nmol/kg, i.c.v.) abolishes the suppressive effects of GABA ( 50 μmol/kg, i.v.) on enhanced renal sympathetic nerve activity (RSNA) during ischaemia, causeing elimination of the renoprotective effects of GABA in rats. |